Clinical trial
Assessment of the Pharmacokinetics of Boceprevir in Pediatric Subjects with Chronic Hepatitis C Genotype 1 (Phase 1b)
To determine weight based doses of boceprevir for children 3 to 17 years of age.
| Category | Value |
|---|---|
| Study start date | 2011-09-08 |